Investment Q&A

• Liminal BioSciences Inc. (LMNL)
  • View LMNL Profile
  • View Questions on LMNL

Q: I would appreciate your comments on PLI's announcement this morning that it plans to acquire all of the shares of Telesta Therapeutics. Also is private equity or a large controlling shareholder behind PLI? In thie press release management exudes a lot of confidence about the future and it is hard to assess whether their confidence is misplaced.

Thank you, Peter

Upvote 0

Read Answer Asked by Peter on August 24, 2016

• Protech Home Medical Corp. (PTQ)
  • Fwd P/E: -32.3X Cap: $232M
  • View PTQ Profile
  • View Questions on PTQ

Q: Hello,

PHM released Q3 financials this morning. I'd appreciate your analysis of the results at your convenience.

Thanks,

Francesco

Upvote 0

Read Answer Asked by francesco on August 24, 2016

• Liminal BioSciences Inc. (LMNL)
  • View LMNL Profile
  • View Questions on LMNL

Q: Hi guys,

Your reaction/thoughts (and the markets) to the purchase of Telesta.

Thanks,

Jim

Upvote 0

Read Answer Asked by jim on August 24, 2016

• Pfizer Inc. (PFE $25.48)
  • $25.48 Fwd P/E: 18.29X Cap: $145.65B
  • View PFE Profile
  • View Questions on PFE

Q: Is this a reasonable alternative to holding onto Phizer?

Upvote 0

Read Answer Asked by Sam on August 24, 2016

• Concordia Healthcare (CXR)
  • View CXR Profile
  • View Questions on CXR

Q: Hi Guys
What is your opinion about Concordia.A lot going on and stock price is down.Is it a good time to buy?
Thanks
Michael

Upvote 0

Read Answer Asked by Michael on August 24, 2016

• Amphastar Pharmaceuticals Inc. (AMPH $22.58)
  • $22.58 Fwd P/E: 11.32X Cap: $1.11B
  • View AMPH Profile
  • View Questions on AMPH

Q: Hi Peter your thoughts? Amphastar Pharmaceuticals (AMPH) It seems to be the maker of narcan for fentanyl overdoses - big problem these days. How's the company itself? Other suggestions due to generics now? Thanks.

Upvote 0

Read Answer Asked by Michael on August 23, 2016

• QHR Corporation (QHR $3.09)
  • View QHR Profile
  • View Questions on QHR

Q: Is the Loblaw offer to QHR a done deal? They say it's a definitive offer. Should I just offer my shares for sale at $3.10.

Upvote 0

Read Answer Asked by Clarence on August 23, 2016

• Medicure Inc. (MPH $1.23)
  • $1.23 Cap: $12M
  • View MPH Profile
  • View Questions on MPH

Q: On Aug. 10th Medicure announced their results for the Qtr. and they looked good to me. What is your take on their results?
Gerry

Upvote 0

Read Answer Asked by Gerry on August 22, 2016

• Neovasc Inc. (NVCN $40.15)
  • $40.15 Cap: $110M
  • View NVCN Profile
  • View Questions on NVCN

Q: As a member of 5iResearch I rec'd an email showing at list of companies with buys, strong buys, Holds, Sell, etc. When I do a search in 5i on this company I cannot find any information. And yet you are listing it as a strong Buy. Could you explain why this would be a good buy.

Upvote 0

Read Answer Asked by Ernie on August 22, 2016

• Miscellaneous (MISC)
  • View MISC Profile
  • View Questions on MISC
  • View Reports on MISC

Q: Cambrex had good momentum and did very well for a while. Any idea why it turned negative ? Should I hold or sell ?

Thank you very much,

Jacques

Upvote 0

Read Answer Asked by Jacques on August 22, 2016

• Protech Home Medical Corp. (PTQ)
  • Fwd P/E: -32.3X Cap: $232M
  • View PTQ Profile
  • View Questions on PTQ

Q: Patient Home Monitoring announced they will hold a conference call on Aug 24th to review the Qtr results and update the market (not shareholders) on plans for 2016 and beyond. Participants will be the CEO and CSO. No mention of the new CFO they announced on June 29th. What's your read on why they wouldn't take this opportunity to formerly introduce the CFO to the market? Do you think this is because the results may be okay and the forward strategy is what they want the market to focus on?

Upvote 0

Read Answer Asked by Gordon on August 22, 2016

• QHR Corporation (QHR $3.09)
  • View QHR Profile
  • View Questions on QHR

Q: I own many stocks from the growth portfolio, but not QHR. Please confirm that, given recent events and it's current price, I shouldn't purchase any now.

Upvote 0

Read Answer Asked by Brenda on August 22, 2016

• CRH Medical Corporation (CRH $4.99)
  • $4.99 Cap: $357M
  • View CRH Profile
  • View Questions on CRH

Q: Can you please provide an update. Thanks

Dave

Upvote 0

Read Answer Asked by David on August 18, 2016

• COSCIENS Biopharma Inc. (AEZS)
  • Cap: $7M
  • View AEZS Profile
  • View Questions on AEZS

Q: I would like your opinion on Aeterna Zentaris(aez).
Thank you for great service.

Milan

Upvote 0

Read Answer Asked by Milan on August 18, 2016

• Concordia Healthcare (CXR)
  • View CXR Profile
  • View Questions on CXR

Q: I see several law firms proceeding with class action activity against CXR. Is it worth while to register for these?

Upvote 0

Read Answer Asked by Zen on August 18, 2016

• QHR Corporation (QHR $3.09)
  • View QHR Profile
  • View Questions on QHR

Q: Can you please comment on QHR earnings please?

Upvote 0

Read Answer Asked by Bill on August 18, 2016

• Miscellaneous (MISC)
  • View MISC Profile
  • View Questions on MISC
  • View Reports on MISC

Q: Hi guys. I have 400 shares of Concordia should I sell and put the proceeds into GUD?
I currently have 2000 GUD shares. Any other recommendations to consider in health care at this time?
Thank you
David

Upvote 0

Read Answer Asked by David on August 18, 2016

• Trillium Therapeutics Inc. (TRIL $23.33)
  • $23.33 Cap: $2.44B
  • View TRIL Profile
  • View Questions on TRIL

Q: Trillium Therapeutics (TR) reported on August 12. Could you please speak about the results and whether this is a continued hold? This is a small position in my portfolio, firmly entrenched in the "speculatives" for now, at 2%. Is it worth adding another percentage point? Thanks, as ever, for your service.

Upvote 0

Read Answer Asked by Sylvia on August 18, 2016

• Novo Nordisk A/S (NVO $69.62)
  • $69.62 Fwd P/E: 19.86X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO

Q: Can you provide your view on Novo Nordisk? It took a real hit last week.
Why did this happen, and what is your view going forward?

Upvote 0

Read Answer Asked by Marco on August 18, 2016

• Concordia Healthcare (CXR)
  • View CXR Profile
  • View Questions on CXR

Q: Gentlemen:
Sorry for another in the string of CXR questions. Early last June, Blackstone and Carlyle dropped their bid for CXR when the shares were selling in the $36.00 range. Considering that the shares have crashed since the acquisition of Amdipharm, can you see a company such as Knight GUD making a bid? They have a strong seasoned management team and have had some financial involvement with the firm. Debt apparently does not come due for another 4 or 5 years.
Thank you

Upvote 0

Read Answer Asked by Martin on August 18, 2016